The Accountability Gap in Biomedical Research: From Data Collection to Publication

Biomedical research is, at its core, a trust-based enterprise. Journals, peer reviewers, and ultimately clinicians and policymakers rely on the assumption that the data underlying published findings are accurate, complete, and faithfully represented. Structural safeguards—including ethics committee review, Good Clinical Practice (GCP), clinical trial monitoring, source data verification (SDV), authorship accountability frameworks, reporting guidelines, and data-sharing policies collectively form an important scaffold around the research process. Yet a meaningful gap persists between the point at which data are generated and the moment they appear in print. This accountability gap does not imply widespread misconduct; most researchers conduct their work with integrity. Rather, it reflects structural and systemic features of academic publishing and research culture that limit verification, incentivise selective reporting, and constrain the ability of readers to independently assess the robustness of published evidence. The present commentary examines where current accountability mechanisms are effective and where limitations remain, drawing on the reproducibility literature, publication ethics discourse, and open science scholarship. We argue that closing the accountability gap requires a shift from trust as the sole guarantor of research quality toward transparent verification as its complement. Practical recommendations are offered for researchers, institutions, funders, and journal editors to strengthen the integrity of the biomedical evidence base without fostering a culture of suspicion among the scientific community.